Product Information
BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0219 per EA under NDC 72888006201. Its NADAC has been published 197 times since Sep 21, 2022.
Strength
5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075521On Market Since
12/29/2020
Price Statistics
The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 197 times since Sep 21, 2022, and over the history we have for it it has declined 22.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0219 per EA |
|---|---|
| All-time high | $0.0314 (Nov 16, 2022) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0232 |
| 52-week low | $0.0214 |
| Median price | $0.0237 |
| Average price | $0.0240 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 197 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0219 per EA (NDC 72888006201), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 22.2%. It has been tracked across 197 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?
Since Sep 21, 2022, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0237 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 5 MG TABLET?
BUSPIRONE HCL 5 MG TABLET (NDC 72888006201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification